Table 1.

Baseline information of 15 innovative anti-cancer medicines.

No.	Name	Dosage form	Strength	Indications	Pharmaceutical company
1	Rituximab	Injection	100 mg/10 ml	Lymphoma	Roche
2	Trastuzumab	Injection	440 mg/20 ml	Breast cancer and gastric cancer	Roche
3	Bevacizumab	Injection	100 mg/4 ml	Colorectal cancer and lung cancer	Roche
4	Sorafenib	Tablet	200 mg	Kidney cancer, hepatocellular carcinoma, and thyroid cancer	Bayer
5	Bortezomib	Injection	13.5 mg	Mantle cell lymphoma	Hansoh, Johnson & Johnson
6	Erlotinib	Tablet	150 mg	Lung cancer	Roche
7	Nimotuzumab	Injection	50 mg/10 ml	Nasopharynx cancer	Biotech Pharma
8	Apatinib	Tablet	250, 425 mg	Gastric adenocarcinoma	Jiangsu Hengrui Pharmaceuticals
9	Chidamide	Tablet	5 mg	Peripheral T-cell lymphoma	Chipscreen Biosciences
10	Fulvestrant	Injection	250 mg/5 ml	Breast cancer	AstraZeneca
11	Everolimus	Tablet	5 mg	Kidney cancer	Novartis
12	Lenalidomide	Capsule	10, 25 mg	Multiple myeloma	Celgene
13	Lapatinib	Tablet	250 mg	Breast cancer	GlaxoSmithKline
14	Abiraterone	Tablet	250 mg	Prostate cancer	Johnson & Johnson
15	Recombinant human endostatin	Injection	15 mg/2.4 ×105U/3 ml	Lung cancer	Simcere